Jiangsu Aidea Pharmaceutical's semi-annual assessment report on the "Quality Improvement and Efficiency Enhancement for Return" action plan for the company in 2024.

SZSI · Aug 23

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.